Katie Eder, Director of Content

The FDA has just approved Shire's Cuvitru for primary immunodeficiency in patients 2 years and older.

Although it's difficult to determine exactly how many patients experience opioid-induced constipation, the large quantities of prescribed opioids in circulation create widespread potential for this bothersome adverse effect.

The opioid overdose death toll has been steadily increasing for more than a decade, making it a leading cause of accidental death in the United States.

There are many misconceptions surrounding pain management, especially when it comes to opioids with abuse-deterrent properties.

Mylan has just announced that it will launch the first generic EpiPen auto-injector at a price of $300 per generic epinephrine 2-pack carton in both 0.15 mg and 0.30 mg strengths.

Customer satisfaction with drugstore chain, mass-merchandiser, supermarket, and mail-order pharmacies has improved across the board in the last year.

For the second time this week, a pharmacist in Ohio was reportedly threatened by a knife-wielding pharmacy robber.

A police officer recently shot and killed a male suspect holding a knife to a Walgreens pharmacist's throat.

The DEA has again rejected a petition to reschedule marijuana, which remains a Schedule I controlled substance under federal law.

A Michigan pharmacist's license to practice has been suspended for the second time because of ongoing alcohol issues.

The Florida Department of Health has issued an order of emergency suspension of the permit of Rock 3, Inc, which does business as Mim's Discount Pharmacy.

A jailed pharmacist in Georgia is awaiting bond on charges for stealing pills from CVS pharmacy and using them in the store.

The owner of 2 Chopin Chemists pharmacies pleaded guilty to what's been called one of the largest opioid diversion schemes ever discovered in New York City.

Communities with significantly less access to pharmacies tend to see higher hospital readmission rates, new study results suggest.

A pharmacist and technician quit their jobs at a pharmacy in Hawaii after a robber threatened them with a BB gun that they thought was a real weapon.

The FDA has just approved Sanofi's lixisenatide (Adlyxin), a new glucagon-like peptide-1 (GLP-1) receptor agonist to improve glycemic control, in conjunction with diet and exercise, in adults with type 2 diabetes.

The former owner of a pharmacy in Lexington, Kentucky, has been sentenced to more than 6 years in prison for stealing $1.1 million from a charity called Chronic Disease Fund.

The nasal spray flu vaccine sold as FluMist Quadravalent shouldn't be used in any setting during the 2016-2017 flu season, according to the CDC's Advisory Committee on Immunization Practices.

The collective recommendations of thousands of pharmacists for more than 1100 OTC brands were revealed today when Pharmacy Times, in collaboration with U.S. News & World Report, announced pharmacists' Top Recommended Health Products for 2016.

Did you know that millions of patients experience dry mouth on an episodic or chronic basis? Or that dry mouth isn't a disease itself, but a symptom of an underlying issue?

The NACDS Foundation is launching a Zika virus education initiative in Puerto Rico that will encourage women to consult pharmacists and physicians about ways to protect themselves and their unborn children.

Brintellix isn't the only drug that underwent a brand name change in order to curb confusion with another drug.

The brand name of the antidepressant Brintellix has been changed to Trintellix in order to avoid prescribing and dispensing errors related to the drug's confusion with the blood thinner Brilinta.

The FDA is continuing to work with clozapine manufacturers to develop a timeline for the program's full implementation.

Advancing collaboration among pharmacy chains and supplier partners to deliver health and wellness solutions throughout the store is the main focus of the fourth annual National Association of Chain Drug Stores Total Store Expo.

There was some degree of unmet demand for pharmacists nationally in January and December, which was a slight improvement from November, when the number of pharmacists looking for work seemed to exceed the number of pharmacist jobs available.

The FDA is requiring a new boxed warning for all immediate-release opioids that outlines the serious risks of opioid misuse, abuse, addiction, overdose, and death.

The number of pharmacists looking for work currently exceeds the number of pharmacist jobs available, according to new data compiled by the Pharmacy Workforce Center.